Oramed Pharma
ORMP----
Oramed Pharma (ORMP)
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Oramed Pharma Analyst Rating
View MoreForecast & Rating
Jun 18, 2026Price forecast
$6.2550.24%
Forecast & Rating-
0analysts
News
- Global Report · Jul 14 at 06:47 AM
The Heterogeneity of Value Chains: From Synthetic Biology to Cloud Aggregators
- PUBT · Jul 7 at 03:31 PM
Lifeward enters USD 5.58 million senior secured convertible note financing with investors, Oramed agent
- TradingView · Jul 2 at 04:10 PM
Oramed Pharmaceuticals COO & Cbo Sold Shares Worth Over $611K
- PUBT · Jul 2 at 04:01 PM
Oramed CFO Avraham Gabay sells 73,360 shares for $330,646.76
- PUBT · Jun 30 at 03:20 PM
Oramed amends bylaws to streamline written-consent record date, delivery rules
- benzinga_article · Jun 25 at 12:03 PM
Oramed shares are trading higher after the company released CEO letter to shareholders, highlighting Russell 2000/3000 index inclusion, Scilex loan repayment, and a strengthened balance sheet.
